As of January 22, 2025, LENSAR (LNSR) has a market cap of $96.403 million USD. According to our data, LENSAR is ranked No.7720 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $96.40 M |
-7.16%
|
Dec 31, 2024 | $0.10 B |
154.70%
|
Dec 29, 2023 | $40.77 M |
18.58%
|
Dec 30, 2022 | $34.38 M |
-50.58%
|
Dec 31, 2021 | $69.57 M |
-17.38%
|
Dec 31, 2020 | $84.21 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
STAAR Surgical
STAA
|
$1.15 B |
0.000 M
|
USA
|
Glaukos
GKOS
|
$8.83 B |
0.000 M
|
USA
|
Market Cap | = | LNSR Stock Price | * | LNSR Shares Outstanding |
= | $8.30 | * | 11.61 M | |
= | $96.40 M |